The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Transcriptional profiling to identify a program of enzalutamide extreme non-response in lethal prostate cancer.
 
Anbarasu Kumaraswamy
No Relationships to Disclose
 
Ya-Mei Hu
No Relationships to Disclose
 
Joel Yates
Stock and Other Ownership Interests - Novo Nordisk
 
Chao Zhang
No Relationships to Disclose
 
Shangyuan Ye
No Relationships to Disclose
 
Charles Ryan
Honoraria - Bayer; Janssen Oncology; Pfizer
Consulting or Advisory Role - ORIC Pharmaceuticals
 
David Quigley
No Relationships to Disclose
 
Rahul Aggarwal
Consulting or Advisory Role - Alessa Therapeutics; Amgen; AstraZeneca; Bayer; BioXcel Therapeutics; Boxer Capital; Curio Science; EcoR1 Capital; Exelixis; Flare Therapeutics; Guidepoint Inc; Harpoon therapeutics; Janssen; Merck; MJH Life Sciences; Novartis; PCCTC; Pfizer; Research to Practice; Slingshot Insights; Tersera; Washington Research Foundation
Research Funding - Amgen (Inst); AstraZeneca (Inst); Janssen (Inst); Merck (Inst); Novartis (Inst); Xynomic Pharma (Inst); Zenith Epigenetics (Inst)
Expert Testimony - University of Utah Health
Travel, Accommodations, Expenses - DAVA Oncology
 
Robert Reiter
Stock and Other Ownership Interests - ImaginAb
Consulting or Advisory Role - Astellas Pharma
Speakers' Bureau - Bayer Schering Pharma; Genomic Health; ImaginAb; Janssen Oncology; Pfizer
Patents, Royalties, Other Intellectual Property - patents surrounding discovery of PSCA and N-cadherin, owned by UCLA (Inst)
 
Tomasz Beer
Employment - Exact Sciences
Stock and Other Ownership Interests - Exact Sciences; Osheru; Osteologic; Salarius Pharmaceuticals
Consulting or Advisory Role - Arvinas; AstraZeneca
 
Matthew Rettig
Consulting or Advisory Role - INMune Bio
Speakers' Bureau - Bayer; Johnson & Johnson
Research Funding - Arvinas (Inst); Fortis (Inst); Novartis (Inst); Progenics
Patents, Royalties, Other Intellectual Property - I am a co-inventor on a patent for novel inhibitors of the N-terminal domain of the AR. There are NO commercial partnerships as of yet.
Travel, Accommodations, Expenses - Johnson & Johnson
 
Martin Gleave
Stock and Other Ownership Interests - Sustained Therapeutics
Honoraria - AbCellera; Astellas Pharma; AstraZeneca; Bayer; Gandeeva; Janssen; Pfizer
Consulting or Advisory Role - AbCellera; Astellas Pharma; AstraZeneca; Bayer; Gandeeva Therapeutics; Janssen; Pfizer
Research Funding - Astellas Pharma; Bayer; Janssen
Patents, Royalties, Other Intellectual Property - ST-CP; ST-POP
 
Primo Lara
Consulting or Advisory Role - Genmab
Research Funding - AstraZeneca (Inst)
 
Josh Stuart
Employment - NantWorks (I)
Stock and Other Ownership Interests - NantWorks
 
George Thomas
Consulting or Advisory Role - Auron Therapeutics; Cygnal Therapeutics; GRAIL
Patents, Royalties, Other Intellectual Property - Patents to UCLA and OHSU (Inst)
 
Felix Feng
Employment - University of California at San Francisco; University of California at San Francisco (I)
Stock and Other Ownership Interests - Artera; Bluestar Genomics; Serimmune
Consulting or Advisory Role - Artera; Astellas Pharma; Bayer; BlueStar Genomics; Bristol Myers Squibb; Bristol Myers Squibb (BMS); Exact Sciences; Foundation Medicine; Janssen Biotech; Myovant Sciences; Novartis; POINT Biopharma; Roivant; SerImmune; Tempus; Varian Medical Systems
Research Funding - Zenith Epigenetics
 
Eric Small
Stock and Other Ownership Interests - Fortis; Teon Therapeutics
 
Zheng Xia
No Relationships to Disclose
 
Joshi Alumkal
Consulting or Advisory Role - FibroGen; ORIC Pharmaceuticals
Research Funding - NCCN/Pfizer; Zenith Epigenetics (Inst)
Travel, Accommodations, Expenses - ORIC Pharmaceuticals